These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 18561324)
1. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324 [TBL] [Abstract][Full Text] [Related]
2. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
4. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer. Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591 [TBL] [Abstract][Full Text] [Related]
5. [Role of silencing PRL-3 expression by miRNA interference in the growth of gastric cancer]. Cai SR; Wang Z; Chen CQ; Cui J; Zhang CH; He YL; Zhan WH Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):618-21. PubMed ID: 18844061 [TBL] [Abstract][Full Text] [Related]
6. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Miskad UA; Semba S; Kato H; Yokozaki H Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667 [TBL] [Abstract][Full Text] [Related]
8. KITENIN is associated with tumor progression in human gastric cancer. Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126 [TBL] [Abstract][Full Text] [Related]
9. Association of EMP1 with gastric carcinoma invasion, survival and prognosis. Sun G; Zhao G; Lu Y; Wang Y; Yang C Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167 [TBL] [Abstract][Full Text] [Related]
10. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563 [TBL] [Abstract][Full Text] [Related]
11. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer. Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911 [TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198 [TBL] [Abstract][Full Text] [Related]
14. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731 [TBL] [Abstract][Full Text] [Related]
15. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma. Fujimoto D; Goi T; Hirono Y Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352 [TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
17. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance. Sun GG; Sheng SH; Jing SW; Hu WN Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900 [TBL] [Abstract][Full Text] [Related]
18. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436 [TBL] [Abstract][Full Text] [Related]
19. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling. Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162 [TBL] [Abstract][Full Text] [Related]
20. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. Zhang C; Tian W; Meng L; Qu L; Shou C J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]